Evernorth, which also houses pharmacy benefit manager Express Scripts, delivered more than 80% of the $181.5 billion in revenue Cigna generated through the first nine months of 2024. Evernorth revenue shot up 31.4% compared with the first three quarters of 2023. In an interview, Perlberg discussed Evernorth’s goal to alleviate the financial burden of specialty drugs and how biosimilar alternatives to brand-name biologic pharmaceuticals fit into the picture.
Read the full article: Evernorth’s Perlberg Bullish on $400B Specialty Pharmacy Market //
Source: https://www.modernhealthcare.com/insurance/evernorth-health-services-matt-perlberg-specialty-pharmacy-cigna